Cargando…

Validating plasminogen activator inhibitor‐1 as a poor prognostic factor in sepsis

AIM: Our previous report indicated that plasminogen activator inhibitor‐1 (PAI‐1) levels of ≥83 ng/mL in patients with sepsis tended to be associated with disseminated intravascular coagulation (DIC), suppressed fibrinolysis, multiple organ dysfunction, and mortality. Therefore, the present study ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoshino, Kota, Nakashio, Maiko, Maruyama, Junichi, Irie, Yuhei, Kawano, Yasumasa, Ishikura, Hiroyasu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642588/ https://www.ncbi.nlm.nih.gov/pubmed/33173586 http://dx.doi.org/10.1002/ams2.581

Ejemplares similares

Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis
por: Hoshino, Kota, et al.
Publicado: (2017)

Outcomes in patients with infections and augmented renal clearance: A multicenter retrospective study
por: Kawano, Yasumasa, et al.
Publicado: (2018)

Glial fibrillary acidic protein level on admission can predict severe traumatic brain injury in patients with severe multiple trauma: A single-center retrospective observational study
por: Nakamura, Yoshihiko, et al.
Publicado: (2022)

Daily combined measurement of platelet count and presepsin concentration can predict in-hospital death of patients with severe coronavirus disease 2019 (COVID-19)
por: Ishikura, Hiroyasu, et al.
Publicado: (2023)

New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study
por: Ishikura, Hiroyasu, et al.
Publicado: (2014)

Augmented renal clearance in Japanese intensive care unit patients: a prospective study
por: Kawano, Yasumasa, et al.
Publicado: (2016)

Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury
por: Nakamura, Yoshihiko, et al.
Publicado: (2014)

Therapeutic Dose Monitoring for Linezolid in a Patient with MRSA Pneumonia with Bacteremia in Diabetes Insipidus
por: Nakamura, Yoshihiko, et al.
Publicado: (2015)

Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study
por: Nakamura, Yoshihiko, et al.
Publicado: (2017)

Comparison of the cytokine adsorption ability in continuous renal replacement therapy using polyethyleneimine-coated polyacrylonitrile (AN69ST) or polymethylmethacrylate (PMMA) hemofilters: a pilot single-center open-label randomized control trial
por: Nakamura, Yoshihiko, et al.
Publicado: (2023)

Coronavirus disease (COVID-19) associated delayed-onset fulminant myocarditis in patient with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
por: Ishikura, Hiroyasu, et al.
Publicado: (2021)

Milk Casein Inhibits Effect of Black Tea Galloylated Theaflavins to Inactivate SARS-CoV-2 In Vitro
por: Nakashio, Maiko, et al.
Publicado: (2023)

Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma
por: Liu, Wen-Jing, et al.
Publicado: (2018)

Net reclassification index in comparison of prognostic value of disseminated intravascular coagulation diagnostic criteria by Japanese Society on Thrombosis and Hemostasis and International Society on Thrombosis and Haemostasis: a multicenter prospective cohort study
por: Mori, Hirotaka, et al.
Publicado: (2023)

Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
por: Iba, Toshiaki, et al.
Publicado: (2017)

Fibrinogen and base excess levels as predictive markers of the need for massive blood transfusion after blunt trauma
por: Umemura, Takehiro, et al.
Publicado: (2015)

Oral Health of COVID-19 Patients Using Extracorporeal Membrane Oxygenation: A Clinical Study of 19 Cases
por: Yoshino, Aya, et al.
Publicado: (2021)

Single measurement of plasminogen activator inhibitor-1 in sepsis: is it useful for evaluating the severity or prognosis of sepsis?
por: Koyama, Kansuke, et al.
Publicado: (2017)

Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study
por: Mori, Hirotaka, et al.
Publicado: (2022)

Correction: Prognostic value of plasma high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study
por: Mori, Hirotaka, et al.
Publicado: (2022)

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
por: Knoop, A., et al.
Publicado: (1998)

Circadian Variation of Plasminogen-Activator-Inhibitor-1 Levels in Children with Meningococcal Sepsis
por: Boeddha, Navin P., et al.
Publicado: (2016)

Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer
por: Witzel, Isabell, et al.
Publicado: (2014)

Effects of tea, catechins and catechin derivatives on Omicron subvariants of SARS-CoV-2
por: Shin-Ya, Masaharu, et al.
Publicado: (2023)

Efficacy of direct hemoperfusion with a polymyxin B‐immobilized fiber column in miliary tuberculosis
por: Kawano, Yasumasa, et al.
Publicado: (2016)

Analysis of the diagnostic capabilities of urinary neutrophil gelatinase‐associated lipocalin and serum procalcitonin for acute kidney injury at the early stage of critical care intensive care unit admission
por: Imoto, Yuji, et al.
Publicado: (2021)

Enhanced effect of recombinant human soluble thrombomodulin by ultrasound irradiation in acute liver failure
por: Hoshino, Kota, et al.
Publicado: (2020)

Thrombomodulin, Plasminogen Activator Inhibitor-1 and Protein C Levels, and Organ Dysfunction in Sepsis
por: Katayama, Shinshu, et al.
Publicado: (2019)

Plasminogen System in the Pathophysiology of Sepsis: Upcoming Biomarkers
por: Napolitano, Filomena, et al.
Publicado: (2023)

Evaluation of Prognostic Values of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Crimean-Congo Hemorrhagic Fever Patients
por: Gurbuz, Yunus, et al.
Publicado: (2015)

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination
por: Nakatsuka, Erika, et al.
Publicado: (2017)

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
por: Lampelj, Maja, et al.
Publicado: (2015)

Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
por: Hoshino, Masami, et al.
Publicado: (2001)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

The Role of Plasminogen Activator Inhibitor 1 in Predicting Sepsis-Associated Liver Dysfunction: An Observational Study
por: Woźnica-Niesobska, Ewa, et al.
Publicado: (2023)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis.
por: Yoshino, H., et al.
Publicado: (1998)

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.
por: Bouchet, C., et al.
Publicado: (1994)

Validation of an immunoassay to measure plasminogen-activator inhibitor-1 concentrations in human saliva
por: Zhang, Xi, et al.
Publicado: (2014)

Risk Factors for Bleeding in Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation and Effects of Transcatheter Arterial Embolization for Hemostasis
por: Goto, Kazuki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k6n0cabauoca4s71estbcqiphm